| Code | CSB-RA009443MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is designed as a research-grade biosimilar to reference antibody ALMB-0166, targeting GJA1 (Gap Junction Alpha-1 protein), also known as Connexin 43 (Cx43). GJA1 encodes the most widely expressed gap junction protein in mammalian tissues, forming intercellular channels that enable direct cell-to-cell communication through the passage of ions, metabolites, and small signaling molecules. This protein plays critical roles in cardiac conduction, embryonic development, wound healing, and cellular homeostasis. Dysregulation of GJA1 has been implicated in various pathological conditions including cardiac arrhythmias, ischemic injury, cancer progression, and inflammatory disorders, making it an important target for investigating intercellular communication mechanisms in health and disease.
This biosimilar antibody provides researchers with a reliable tool for investigating GJA1 expression, localization, and function across diverse experimental systems. It supports studies examining gap junction biology, cell signaling pathways, tissue development, and disease mechanisms where connexin-mediated communication is disrupted or altered. The antibody facilitates research into potential therapeutic strategies targeting gap junction proteins.
There are currently no reviews for this product.